CCL Industries (CCL-B) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Q2 2024 sales rose 12.2% year-over-year to $1.85B, driven by 8.5–9% organic growth, acquisitions, and currency effects.
Operating income increased 25–25.4% to $303.5M, with net earnings up 79.3% to $279.5M, including a $78.1M revaluation gain from the Pacman-CCL acquisition.
Adjusted basic EPS set a record at $1.13, up 25.6% year-over-year.
All four segments posted organic sales growth, with Checkpoint leading at 17.5%.
Pacman-CCL is now fully consolidated following the acquisition of the remaining 50%.
Financial highlights
Q2 EBITDA rose 21–21.1% to $386.7M; operating margin reached 16.4% (up 170 bps).
Free cash flow from operations was $118.8M for Q2 and $567.8M for the trailing twelve months.
Net debt at June 30, 2024, was $1.76B, leverage ratio at 1.23x EBITDA.
Effective tax rate dropped to 18.8% due to a non-cash gain.
Adjusted EBITDA margin for Q2 was 20.9%.
Outlook and guidance
Management expects continued strong performance in H2 2024, with Innovia's $17–$20M annual operating income improvement to begin in H2.
CCL Design recovery expected to remain strong; CCL Secure to slow in Q3 but improve in Q4.
Avery progress steady; Checkpoint RFID growth to continue; Innovia to benefit from operational savings.
Currency translation impact expected to be neutral for Q3 2024.
Ongoing focus on global expansion, supported by robust liquidity and undrawn credit capacity.
Latest events from CCL Industries
- Record 2025 sales, earnings, and cash flow drove higher shareholder returns and stable 2026 outlook.CCL-B
Q4 202526 Feb 2026 - Q3 delivered strong sales and earnings growth, led by Checkpoint and Innovia, with robust liquidity.CCL-B
Q3 202414 Jan 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025 - Q3 sales and earnings rose, led by CCL and Checkpoint, with strong cash flow and $467.9M returned.CCL-B
Q3 202512 Nov 2025